EU Guide On Handling IMPs Draws Industry Concern
Executive Summary
Pharmaceutical companies believe that some aspects of the draft EU guideline are potentially confusing or may be difficult to implement.
You may also be interested in...
Sponsors Told How To Manage IMPs Under EU Clinical Trials Regulation
The release process for investigational medicinal products, shipping and contractual arrangements are among the topics discussed in guidance that came into effect on 1 January.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.